Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2020-04-30
2022-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Obstructive Sleep Apnea
Subjects will undergo 6 weeks of whole body vibration.
Whole Body Vibration
Subjects will undergo whole body vibration (standing on a "power plate" device 3 times a week, for 30 minute sessions, for 6 weeks)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Whole Body Vibration
Subjects will undergo whole body vibration (standing on a "power plate" device 3 times a week, for 30 minute sessions, for 6 weeks)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* new diagnosis of moderate to severe OSA (via overnight polysomnography)
* and able to lay flat (requirement for brain MRI)
* must have space and electrical power access for WBV device at their home
Exclusion Criteria
* currently using (or will start using during 6-week study period) CPAP or BiPAP or oral appliance for OSA treatment
* recent (\<6 months) myocardial infarction
* current pregnancy (if subject is female)
* history of stroke
* diagnosed psychiatric disease (schizophrenia, manic-depressive)
* airway or chest deformities that would interfere with breathing
* mechanical ventilatory support
* renal failure (requiring dialysis)
For brain MRI
* claustrophobia
* metallic-based tattoos
* metallic implants or devices (such as implantable cardioverter-defibrillator, pacemaker, embolic coils, aneurysm clips) or any other material that could be hazardous in MRI scanner
* body weight \>300 lbs (restrictions of MRI scanner table)
40 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Los Angeles
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19-006112
Identifier Type: -
Identifier Source: org_study_id